| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.2M | +136.4% |
| Cost of Revenue | $1.3M | +108.2% |
| Gross Profit | $906K | +191.3% |
| R&D Expense | $90K | -75.8% |
| SG&A Expense | $1.3M | +178.9% |
| Operating Income | -$7.2M | -13.4% |
| Net Income | -$7.4M | -17.6% |
| EPS (Basic) | -$0.70 | +11.4% |
| EPS (Diluted) | -$0.70 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $124K | -24.3% |
| Inventory | $342K | -4.8% |
| Current Assets | $2.8M | +115.9% |
| Total Assets | $4.9M | +44.3% |
| Current Liabilities | $894K | -36.9% |
| Long-term Debt | $146K | — |
| Total Liabilities | $1.1M | -35.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.1M | -104.4% |
| Capital Expenditures | $64K | +111.5% |
| Investing Cash Flow | -$436K | -1346.3% |
| Financing Cash Flow | $5.8M | +488.7% |
| Free Cash Flow | -$4.2M | -104.5% |
| +11.4% |
| Stockholders' Equity |
| $3.9M |
| +118.1% |